The Yorkshire-based Biotechnology company, Kirkstall Ltd is hosting an event which will discuss the latest research into in-vitro testing.
Kirkstall Ltd develops innovative testing technologies at its Kroto Innovation Centre laboratories based in Sheffield. The biotech company will be hosting the event to discuss new developments in human-cell based testing in Montpellier in France on May 26th and May 26th.
Topics covered will span from regulatory procedures to reducing the need for animal testing. Not only this, but Sheila MacNeil, a professor at the University of Sheffield will be presenting her paper on 3d tissue engineering models for research and development.
Kirkstall recently received by than £100,000 of equity funding following its involvement in Grant Thornton’s Investing in Health programme. The funding has enabled the biotech company to further develop its technologies whilst building on its reputation. This has lead to the biotechnology company to win its first significant three-year contact in toxicity testing.
Managing Director of Kirkstall, Malcom Wilkinson, has stated, “We’ve had a fantastic response to the event so far with more than 90 people registered to attend. The key reason there is so much interest is that there are some serious unmet needs at the moment in toxicity testing which our technologies can address.
“It is a great opportunity to bring together leading researchers from the industry and also shows the benefits of working with academic research teams and key opinion leaders in the biotechnology market place.”
Looking for a job in the biotechnology industry? Click here to search our current biotech jobs now.